About MADERA THERAPEUTICS LLC
Madera Therapeutics is a biotechnology company focused on developing next-generation ClpP agonist therapeutics to target cancer's mitochondrial vulnerabilities and overcome treatment resistance. Their agents activate ClpP, a mitochondrial protease, to create therapeutic vulnerabilities in cancer cells.
Development of next-generation ClpP agonist therapeuticsActivation of mitochondrial protease ClpP for anticancer activityResearch on drug-resistant cancer models including KRAS-mutant pancreatic cancerPatent portfolio covering ClpP activators and therapeutic uses in oncology
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to MADERA THERAPEUTICS LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.